Breakthrough T1D Timeline: Stem Cell Therapies
Stem cells have the potential to lead to treatments for type 1 diabetes, but it has taken Breakthrough T1D more than 20 years to get to this point.
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
At the ADA’s Scientific Sessions, Breakthrough T1D scientists presented on some of the most important topics, all with the same goal: Ending type 1 diabetes.
Breakthrough T1D Heads—In Person!—to ADA’s 82nd Scientific Sessions
From June 3-7, diabetes researchers around the world will gather—in person!—at the American Diabetes Association’s 82nd Scientific Sessions. #JDRFxADA
FDA Approved! Abbott FreeStyle Libre® 3 Continuous Glucose Monitor, Ages 4+
The FDA cleared the FreeStyle Libre 3 continuous glucose monitor (CGM) for children and adults ages 4 and up with diabetes
Moonshot Reimagined: Our Vision to Halt and Reverse Vision Loss
Breakthrough T1D has taken a bold new step to prevent and restore vision loss and blindness: Restoring Vision Moonshot, in honor of Mary Tyler Moore.
100, 100: Ending Diabetic Eye Disease, Forever
Breakthrough T1D has supported eye disease research since its beginning, and has driven discoveries that have reduced the risk of blindness by 95%.
Breakthrough T1D Video: No Health Without Mental Health
Find out why we absolutely love psychologist Jill Weissberg-Benchell.
Top Researchers Gather for the 15th ATTD Conference
Leading researchers gathered, in person, for the annual meeting of the ATTD Conference (April 27-30), featuring 30+ studies presented by Breakthrough T1D scientists.
An Enemy You Can Beat: T1D in Video Games
We're continuing that trend by putting the spotlight on video games and game developers with links to T1D.
Vertex Provides an Update on the VX-880 Clinical Trial
Vertex provides an update on their Phase 1/2 Clinical Trial for VX-880, including data from three participants and details around the clinical hold.
